ArticleJCI insight2020

Inhibition of DDR1 enhances in vivo chemosensitivity in KRAS-mutant lung adenocarcinoma.

Marie-Julie Nokin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.